[Pancreatic duct occlusion from the clinical viewpoint: exocrine and endocrine consequences].
Schneider
M U
MU
Medizinische Klinik mit Poliklinik der Universität Erlangen-Nürnberg.
D000818:Animals; D002908:Chronic Disease; D003973:Diatrizoate; D004338:Drug Combinations; D005227:Fatty Acids; D006801:Humans; D016035:Pancreas Transplantation; D010183:Pancreatic Ducts / Q000601:surgery*; D010186:Pancreatic Function Tests; D010195:Pancreatitis / Q000601:surgery*; D011183:Postoperative Complications / Q000209:etiology*; D011409:Propylene Glycols; D011506:Proteins / Q000008:administration & dosage; D015028:Zein
D004338:Drug Combinations; D005227:Fatty Acids; D011409:Propylene Glycols; D011506:Proteins; D003973:Diatrizoate; D015028:Zein; C020481:alcoholic prolamine solution
Pankreasgangocclusion aus klinischer Sicht: exokrine und endokrine Konsequenzen.